Arrhythmias & electrophysiology

High-Resolution Mapping vs Differential Pacing in Evaluating Atrial Linear Lesions and the Impact of Pseudoblocks on Atrial Tachycardia Risk

JACC Clin ElectrophysiolPublished Study

Authors' conclusion

The systematic use of HRM for line assessment allows to unmask a substantial proportion of pseudoblocks not identified by DP. The existence of a persistent residual conduction through a line is associated with a high risk of AT during follow-up.

Study context

Population
Patients who underwent atrial tachycardia (AT) or persistent atrial fibrillation ablation with ≥1 atrial linear lesionpatients, 101 cavotricuspid isthmus lines, 85 roof lines, and 84 mitral isthmus lines evaluated · cavotricuspid isthmus lines 101 · roof lines 85 · mitral isthmus lines 84
Participants
102 patients
Comparison
Conventional differential pacing (DP) criteria vs high-resolution mapping (HRM) for line assessment
Outcome
Residual conduction across cavotricuspid isthmus lines
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

Lines with residual conduction by HRM

38 lines

37.6%

DP false-positive, of the 38 lines with residual conduction

14 cases

37%

Further findings

OutcomeAll attempted lines successfully blocked≥1 line that remained unblocked
AT-free survival · 1 year95.4%31.9%

Residual conduction across roof lines

Lines with residual conduction
40 lines (47.1%)
DP false-positive, of the 40 lines with residual conduction
16 (40%)

Residual conduction across mitral isthmus lines

Lines with residual conduction
24 lines (28.6%)
DP false-positive, of the 24 lines with residual conduction
13 (54%)

Original publication

High-Resolution Mapping vs Differential Pacing in Evaluating Atrial Linear Lesions and the Impact of Pseudoblocks on Atrial Tachycardia Risk. JACC Clin Electrophysiol. Published 16 April 2025. doi:10.1016/j.jacep.2025.02.042

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.